Burn Injury Medication Management in Personal Injury Cases

James Wong — Founder & Pharmacist, LienScripts | August 23, 2024 | 7 min read

Burn injuries from accidents — fires, chemical exposure, scalding liquids, or electrical contact — are among the most medically intensive injuries in personal injury cases. Learn about the multi-phase medication needs of burn survivors and how a pharmacy lien provides uninterrupted prescription access throughout recovery.

Burn Injury Medication Management in Personal Injury Cases

Burns sustained in accidents — whether from fires, chemical spills, electrical contact, or hot liquids — are among the most complex and painful injuries a personal injury patient can experience. The medical trajectory of a serious burn does not follow a simple arc of injury and recovery. Instead, it unfolds across multiple clinical phases, each with distinct medication needs, over a treatment timeline that can span many months.

For attorneys handling burn injury cases and for patients living through burn recovery, understanding the pharmaceutical dimension of treatment — what is prescribed, why, and for how long — is essential to building an accurate and complete picture of the case.

[!KEY] Burn injury treatment unfolds across three distinct clinical phases — acute wound management, subacute healing, and reconstructive — each with its own medication profile, and a pharmacy lien enrolled at intake covers all three phases without interruption.

Understanding Burn Degree and What It Means for Medication

The depth of a burn injury determines not just the initial treatment but the entire medication timeline.

Superficial (first-degree) burns affect only the outermost layer of skin (epidermis). These typically require only topical wound care and over-the-counter analgesics and do not generally give rise to personal injury cases unless the area affected is extensive.

Partial-thickness (second-degree) burns involve the epidermis and varying depths of the dermis. These are characterized by blisters, intense pain, weeping wound beds, and high infection risk. Superficial partial-thickness burns may heal in 2 to 3 weeks with appropriate wound care; deep partial-thickness burns often require weeks of intensive wound management and may require skin grafting.

Full-thickness (third-degree) burns destroy both the epidermis and dermis and may extend into subcutaneous tissue, muscle, or bone. These burns require surgical intervention — debridement and skin grafting — and carry the longest and most medically intensive recovery timelines.

The degree and total body surface area (TBSA) burned determine the entire medication profile.

Acute Phase: Wound Management, Pain Control, and Infection Prevention

The acute phase of burn treatment encompasses initial wound stabilization and early healing — typically the first days to several weeks following the injury.

Analgesics: Burn Pain Is in a Category of Its Own

Burn pain is widely recognized by clinicians as one of the most severe pain experiences in medicine. It is also a pain that worsens with routine wound care — dressing changes and debridement are intensely painful procedures that must be performed regularly.

• Opioid analgesics are the standard of care for significant burn pain in the acute phase. Oral oxycodone or hydromorphone may be prescribed for background pain; breakthrough dosing is often required around wound care procedures
• Intravenous morphine is used in the acute hospital phase for patients with serious burns requiring inpatient care
• Ketamine at sub-anesthetic doses is increasingly used by burn specialists as a procedural analgesic adjunct during dressing changes, providing dissociative analgesia with less opioid requirement

As wounds progress through healing stages and pain burden shifts from acute nociceptive pain to itch and neuropathic discomfort, the analgesic regimen is adjusted accordingly.

Topical Antimicrobials: The Front Line Against Wound Infection

The destroyed skin barrier eliminates the body's primary defense against infection. Topical antimicrobials are applied directly to burn wounds to suppress bacterial colonization and prevent wound bed infection.

• Silver sulfadiazine (Silvadene) 1% cream — the most widely used topical antimicrobial for burn wounds; it provides broad-spectrum coverage and maintains a moist wound environment
• Mafenide acetate (Sulfamylon) — preferred for wounds where deep penetration is required, particularly full-thickness burns and ear burns, though it causes burning pain on application
• Bacitracin zinc — used for superficial burns and facial burns where silver sulfadiazine's potential pigmentation effect is a concern
• Silver-containing dressings (e.g., Mepilex Ag, Aquacel Ag) — prescription-strength advanced wound dressings that provide sustained silver release; these are dispensed through pharmacies and represent a significant prescription cost in burn cases

Systemic Antibiotics for Established Infection

When wound infections develop or the patient develops signs of systemic infection (sepsis), systemic antibiotics are prescribed. The choice is guided by wound culture results. Common agents include piperacillin-tazobactam, vancomycin (for MRSA coverage), and others based on the identified pathogen.

[!KEY] The multi-drug, multi-phase nature of burn treatment — opioids, topical antimicrobials, anxiolytics, antihistamines, scar agents, and psychiatric medications across an extended timeline — produces a pharmacy record with a complexity that is itself strong evidence of a serious, non-trivial injury.

Anxiolytics: Managing Procedural Anxiety

Wound dressing changes and debridement create intense procedural anxiety. Short-course benzodiazepines — lorazepam or diazepam — are sometimes prescribed in the acute and subacute phases specifically for pre-procedural anxiety management. This is clinically appropriate and represents a recognized pharmaceutical need in burn recovery.

Subacute Phase: Wound Healing, Itch, and Scar Modulation

As wounds begin to close — whether through spontaneous re-epithelialization or surgical grafting — the clinical focus shifts to optimizing healing and managing the significant discomfort that accompanies it.

Managing Pruritus (Itch)

Wound healing itch is one of the most distressing and underappreciated symptoms of burn recovery. As new nerve endings regenerate through healing tissue, they produce intense, constant itching that is difficult to relieve and can significantly disrupt sleep and quality of life.

• Diphenhydramine (Benadryl) — often prescribed for bedtime itch management, though sedation limits daytime use
• Hydroxyzine (Vistaril) — a preferred antihistamine for burn itch due to its anxiolytic properties; also helps with sleep disruption
• Gabapentin — increasingly recognized as an effective agent for burn wound itch, working via its action on sensory nerve pathways; also provides concomitant benefit for neuropathic pain
• Doxepin — a low-dose tricyclic with antihistamine properties sometimes used for refractory itch

Sleep Medications

Pain, itch, and the psychological burden of burn injury combine to severely disrupt sleep. Persistent sleep disruption slows wound healing and impairs immune function. Prescription sleep aids — trazodone, mirtazapine, or hydroxyzine — are commonly prescribed throughout the subacute recovery period.

Nutritional Support

Burn injuries dramatically increase metabolic demands. Protein and micronutrient supplementation — vitamin C, zinc, vitamin D — are frequently prescribed to support wound healing. These may be dispensed through a pharmacy when prescribed in therapeutic doses.

Reconstructive Phase: Post-Grafting and Scar Management

Patients with full-thickness or deep partial-thickness burns who require skin grafting enter a reconstructive phase that can last for months to over a year, with ongoing medication needs.

Post-Surgical Medications

• Opioid analgesics — harvest site pain (where donor skin is taken) is often reported as more painful than the burn wound itself; opioid coverage continues in the post-grafting period
• Antibiotics — surgical prophylaxis and graft site infection prevention

Scar Management

Hypertrophic scar formation is nearly universal in partial and full-thickness burns. Medical-grade scar management agents include:

• Silicone gel sheets and silicone gel — the standard non-surgical scar management intervention; prescription-grade silicone gel products are dispensed through pharmacies
• Triamcinolone acetonide injections — intralesional corticosteroid injections performed by the treating surgeon or dermatologist for raised, rigid hypertrophic scars

Mood and Psychological Medications

Depression, PTSD, and anxiety are documented complications of serious burn injuries. The disfigurement, prolonged treatment course, pain burden, and life disruption of a major burn create significant psychological sequelae. Antidepressants — SSRIs such as sertraline or fluoxetine, or SNRIs such as duloxetine — are commonly initiated during the subacute or reconstructive phase.

[!NOTE] The extended prescription record created by a pharmacy lien in a burn case is itself evidence of case severity — a multi-month pharmacy history spanning wound care agents, opioid analgesics, antihistamines for pruritus, and psychiatric medications documents a treatment burden that soft tissue cases rarely approach.

Long Treatment Timelines and the Pharmacy Lien

The multi-phase nature of burn injury treatment means that prescription needs extend for months and sometimes well over a year after the initial injury. A pharmacy lien enrolled at the outset of the case remains active throughout this entire period, providing uninterrupted prescription access.

This is particularly important because burn cases often take longer to resolve than soft tissue vehicle accident cases. The extended litigation timeline means the patient needs sustained prescription access — and the extended prescription record created by a pharmacy lien is itself a powerful documentation of the case's severity.

[!KEY] In burn cases, enroll the client in the pharmacy lien at the acute phase — not after discharge — because early wound care agents (silver sulfadiazine, prescription dressings) are among the highest-cost items in the record and their omission creates a documentation gap in the earliest and most intensive phase of treatment.

LienScripts' pharmacy lien covers all phases of burn treatment — topical wound care agents, opioid analgesics, anxiolytics, antihistamines, neuropathic agents, scar management products, and post-surgical medications — at zero upfront cost throughout the case.

To learn more about accessing your prescriptions without upfront costs, visit our patient resources page.

Related Resources

• Patient Resources
• Specialty Medications in Personal Injury Cases
• How Long Will I Need Medications After an Accident?
• Pharmacy Services for Personal Injury Clients: How It Works
• Gabapentin for Personal Injury Cases: What Attorneys Need to Know